preeclampsia
Conditions
Interventions
administration of statin Participants take pravastatin 10mg per day from diagnosis of preeclampsia to termination. If participants have severe hyperlipemia, they take pravastatin 20mg per day.
non-a
Sponsors
Kyoto University Department of Gynecology and Obstetrics
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients who have preeclampsia with hyperlipemia.
Exclusion criteria
Exclusion criteria: Unconsented by patients or therapist cyclosporin therapy Past history of rhabdomyolysis Past history of allergic reaction for statins
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| maternal blood pressure, body weight, edema, liver function, kidney function, serum lipids, urinary protein | — |
Secondary
| Measure | Time frame |
|---|---|
| obstetric history, age, postpartum blood pressure, body weight, edema, liver function, kidney function, serum lipids, urinary protein until one week, extend the period of pregnancy, maternal serum soluble fms-like tyrosine kinase 1, maternal serum tumor necrosis factor alfa, maternal urine F2-Isoprostanes | — |
Countries
Japan
Contacts
Public ContactShingo Io
Kyoto University Department of Gynecology and Obstetrics
Outcome results
None listed